Skip to main content
Fig. 5 | BMC Biotechnology

Fig. 5

From: Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen

Fig. 5

HBsAg-binding activity of pseudotype VLPs harbouring anti-HBsAg molecules determined by ELISA. Concentrations (pM) of anti-HBsAg fused proteins scFv-Fc-VP2 and scFv-VP2 displayed on the respective pseudotype VLPs are indicated. As a positive control, full-length parental MAb HB1 is used. As a negative control, VP1/GFP-VP2 pseudotype VLPs are used

Back to article page

BMC Biotechnology

ISSN: 1472-6750

Contact us